PAMELA SLOOP: Open Payments
NPI 1952442527 · NORTH WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 62 payments from 15 companies in 2025. Trend: 2023 $838 · 2024 $601 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $288 |
| PFIZER INC. | 6 | $140 |
| Ardelyx, Inc. | 5 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Corcept Therapeutics | 2 | $34 |
| Novo Nordisk Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: IBSRELA, NURTEC ODT, UBRELVY, XIFAXAN, VRAYLAR, QULIPTA, Kerendia, Symbravo.
Industry payments across NC — which companies pay providers there.
